These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19325845)

  • 1. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
    Shimizu M; Shirakami Y; Moriwaki H
    Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
    Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
    J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
    Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
    Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
    Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
    Sah JF; Balasubramanian S; Eckert RL; Rorke EA
    J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M; Deguchi A; Joe AK; Mckoy JF; Moriwaki H; Weinstein IB
    J Exp Ther Oncol; 2005; 5(1):69-78. PubMed ID: 16416603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
    Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate.
    Afaq F; Adhami VM; Ahmad N; Mukhtar H
    Oncogene; 2003 Feb; 22(7):1035-44. PubMed ID: 12592390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
    Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
    Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
    Chung JY; Huang C; Meng X; Dong Z; Yang CS
    Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL; Cardelli JA
    Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights of dietary polyphenols and obesity.
    Wang S; Moustaid-Moussa N; Chen L; Mo H; Shastri A; Su R; Bapat P; Kwun I; Shen CL
    J Nutr Biochem; 2014 Jan; 25(1):1-18. PubMed ID: 24314860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.
    Zhang Q; Tang X; Lu Q; Zhang Z; Rao J; Le AD
    Mol Cancer Ther; 2006 May; 5(5):1227-38. PubMed ID: 16731755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.